Clinical trial

Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer

NCT06928389

StatusRECRUITING
Study typeINTERVENTIONAL
Start date2025-07-08
PhasePHASE3

Study timeline

Study start (actual)2025-07-08Date precision: day
Registry last updated2026-04-09
Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Sponsors & collaborators

Akesolead sponsor

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.